Pulmonary Tuberculosis I
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Toxicity: Overview
Drug Toxicity: Risk factors
Drug toxicity: Drug–Drug Interaction
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Jun 24, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
乙型肝炎病毒 (HBV) adw亚型携带者在抗病毒治疗期间面临的拉米武丁耐药性发展的风险高于ayw亚型携带者. 这种风险增加可能与乙型肝炎表面抗原 (HBsAg) 的同时变化有关.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论:
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
11:06Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022